Skip to main content

Table 1 Summary of Patients Treated

From: Feasibility investigation of allogeneic endometrial regenerative cells

Patient Condition Route Total Injected Follow Up Notable Events
AA MS IV & IT 16 million 12 months None
PW MS IT 30 million 2 months None
RH MS IT 30 million 2 months None
JU MS IT 30 million 5 months None
\